SCNI
Scinai Immunotherapeutics
SCNI
SCNI
7 hedge funds and large institutions have $271K invested in Scinai Immunotherapeutics in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-4
Holders Change %
-36.36%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$4K |
Top Sellers
| 1 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BHB
1
Bank Hapoalim BM
Tel Aviv,
Israel
| $144K | – | – | – |
|
2
HighTower Advisors
Chicago,
Illinois
| $97K | – | – | – |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
|
6
Morgan Stanley
New York
| $4K | +$1.14K | +2 | +40% |
|
|
II
7
Ibex Investors
Denver,
Colorado
| $2.07K | – | – | – |
|
|
PVH
8
Psagot Value Holdings
Tel Aviv,
Israel
| – | -$59K | -109 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$5K | -9 | Closed |
|